Published in Endocrinology on December 01, 1994
Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J (2000) 1.46
Transcriptional repression by the orphan steroid receptor RVR/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis. Nucleic Acids Res (1996) 1.04
Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle. J Endocrinol (2005) 1.00
Characterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-gamma: evidence that the AF-1 region functions in a cell-specific manner. Nucleic Acids Res (1996) 0.85
Bioinformatic identification of novel putative photoreceptor specific cis-elements. BMC Bioinformatics (2007) 0.77
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev (1988) 6.23
A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev (1998) 4.78
Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet (2000) 4.74
Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev (2000) 4.00
SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol (1997) 3.84
Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature (2000) 3.41
Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell (2001) 2.69
Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev (2001) 2.68
Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc Natl Acad Sci U S A (1999) 2.10
Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (1988) 1.95
Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet (1997) 1.70
Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol (2001) 1.69
A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem (2001) 1.68
MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet (2001) 1.67
The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev (2000) 1.59
Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am J Hum Genet (1996) 1.59
Contrast nephrotoxicity and iso-osmolar contrast agents: implications of NEPHRIC. Clin Radiol (2003) 1.39
The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucleic Acids Res (1998) 1.39
Nucleotide sequence and expression of the human skeletal alpha-actin gene: evolution of functional regulatory domains. Genomics (1988) 1.37
Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res (1996) 1.28
Corepressors and nuclear hormone receptor function. Curr Top Microbiol Immunol (2001) 1.24
Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene. Am J Hum Genet (1997) 1.23
Cell salvage auto transfusion in total knee replacement surgery. Transfus Med (1997) 1.21
Design variability in web geometry of an orb-weaving spider. Physiol Behav (1997) 1.17
Active repression of RAR signaling is required for head formation. Genes Dev (2001) 1.16
Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells. Mol Endocrinol (2001) 1.14
Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family. Mol Endocrinol (1995) 1.13
Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. Clin Cancer Res (2001) 1.09
The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol Endocrinol (1999) 1.08
Identification of a thyroid hormone response element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site. Cell Growth Differ (1993) 1.07
Partitioning effects during terminal carbon and electron flow in sediments of a low-salinity meltwater pond near Bratina Island, McMurdo Ice Shelf, Antarctica. Appl Environ Microbiol (1999) 1.05
Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene (2011) 1.05
The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene (1995) 1.04
Regulation of vertebrate muscle differentiation by thyroid hormone: the role of the myoD gene family. Bioessays (1995) 1.04
Transcriptional repression by the orphan steroid receptor RVR/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis. Nucleic Acids Res (1996) 1.04
Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta. Mol Endocrinol (1995) 1.02
Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD. Nucleic Acids Res (1999) 1.02
Activation of myoD gene transcription by 3,5,3'-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors. Nucleic Acids Res (1994) 1.01
Trans-activation and DNA-binding properties of the transcription factor, Sox-18. Nucleic Acids Res (1995) 1.00
Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains. Mol Endocrinol (2000) 1.00
Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration. Antimicrob Agents Chemother (1991) 0.97
Broad binding-site specificity and affinity properties of octamer 1 and brain octamer-binding proteins. Eur J Biochem (1993) 0.97
Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha. Mol Endocrinol (1998) 0.97
Changes in levels of actin and tubulin mRNAs upon the lectin activation of lymphocytes. Mol Cell Biol (1984) 0.96
Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? Development (1992) 0.96
Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis. Nucleic Acids Res (1995) 0.95
Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1. J Mol Endocrinol (1998) 0.95
Characterization of the thyroid hormone response element in the skeletal alpha-actin gene: negative regulation of T3 receptor binding by the retinoid X receptor. Cell Growth Differ (1993) 0.94
Parallel origins of duplications and the formation of pseudogenes in mitochondrial DNA from parthenogenetic lizards (Heteronotia binoei; Gekkonidae). J Mol Evol (1991) 0.94
Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur J Biochem (2000) 0.94
A polymorphism in the agouti signalling protein (ASIP) is associated with decreased levels of mRNA. Pigment Cell Res (2006) 0.94
Sequence and expression of Sox-18 encoding a new HMG-box transcription factor. Gene (1995) 0.94
Transcriptional repression by COUP-TF II is dependent on the C-terminal domain and involves the N-CoR variant, RIP13delta1. J Steroid Biochem Mol Biol (1998) 0.93
The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD. Nucleic Acids Res (1998) 0.92
A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes. Eur J Cancer Care (Engl) (1999) 0.92
'Eruptive' amelanotic compound nevi in children with facial freckles and pale skin colour: more than an occasion? J Eur Acad Dermatol Venereol (2013) 0.91
SOX18 directly interacts with MEF2C in endothelial cells. Biochem Biophys Res Commun (2001) 0.91
Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox18. Mol Pharmacol (2001) 0.90
Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA. Lab Invest (2001) 0.89
Cloning and functional analysis of the Sry-related HMG box gene, Sox18. Gene (2001) 0.88
Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. Nucleic Acids Res (1996) 0.88
The tissue-specific chicken histone H5 gene is transcribed with fidelity in Xenopus laevis oocytes. J Mol Biol (1985) 0.88
Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target. J Mol Biol (1999) 0.87
Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells. Biochem Pharmacol (1997) 0.87
A gel mobility shift assay for probing the effect of drug-DNA adducts on DNA-binding proteins. Methods Mol Biol (1997) 0.86
Characterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-gamma: evidence that the AF-1 region functions in a cell-specific manner. Nucleic Acids Res (1996) 0.85
Complete sequence and polymorphism study of the human TYRP1 gene encoding tyrosinase-related protein 1. Mamm Genome (1998) 0.85
The human melanocortin-1 receptor locus: analysis of transcription unit, locus polymorphism and haplotype evolution. Gene (2001) 0.84
Injection-associated pain in femoral arteriography: a European multicenter study comparing safety, tolerability, and efficacy of iodixanol and iopromide. Cardiovasc Intervent Radiol (1997) 0.83
The retinoic acid and retinoid X receptors are differentially expressed during myoblast differentiation. Endocrinology (1994) 0.83
The marsupial MHC: the tammar wallaby, Macropus eugenii, contains an expressed DNA-like gene on chromosome 1. J Mol Evol (1994) 0.83
Effects of carbohydrate supplementation during intense training on dietary patterns, psychological status, and performance. Int J Sport Nutr (1995) 0.82
Structure, mapping, and expression of human SOX18. Mamm Genome (2000) 0.81
Nuclear receptors and AMPK: resetting metabolism. Cold Spring Harb Symp Quant Biol (2012) 0.81
The human skeletal alpha-actin promoter is regulated by thyroid hormone: identification of a thyroid hormone response element. Cell Growth Differ (1992) 0.81
Biphasic response of the metallothionein promoter to ultraviolet radiation in human melanoma cells. Photochem Photobiol (1997) 0.80
One year clinical outcomes of renal artery stenting: the results of ODORI Registry. Cardiovasc Intervent Radiol (2009) 0.80
Inhibition of melanin synthesis by cystamine in human melanoma cells. J Invest Dermatol (2000) 0.80
Dinucleotide repeat polymorphism at the human TYRP1 locus. Hum Mol Genet (1994) 0.80
Expression and cytoplasmic localisation of deoxyuridine triphosphate pyrophosphatase encoded by a human endogenous retrovirus. Arch Virol (2000) 0.79
Monoclonal antibodies against plant proteins recognise animal intermediate filaments. Cell Motil Cytoskeleton (1987) 0.79
Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts. Cancer Res (1983) 0.79
Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extraction. Melanoma Res (1998) 0.79
Growth-related changes in specific mRNAs upon lectin activation of human lymphocytes. DNA (1985) 0.79
Sequence of the human dopachrome tautomerase-encoding TRP-2 cDNA. Gene (1994) 0.78
Osteopontin expression in plasma of melanoma patients and in melanocytic tumours. J Eur Acad Dermatol Venereol (2011) 0.78
The effects of lectin transformation on cytoplasmic polyadenylated RNA from human lymphocytes. Mol Cell Biochem (1983) 0.78
Inhibition of retinoblastoma protein translation by UVB in human melanocytic cells and reduced cell cycle arrest following repeated irradiation. Oncogene (1996) 0.78
Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells. Biochem Pharmacol (1994) 0.78
In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts. Pigment Cell Res (1993) 0.78
Sox18 expression in blood vessels and feather buds during chicken embryogenesis. Gene (2001) 0.77
UVB-specific regulation of gene expression in human melanocytic cells: cell cycle effects and implication in the generation of melanoma. Mutat Res (1998) 0.77